MRNA Today - Aug 10: Small Gains Amid Mixed News
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
MRNA Today - Aug 10: Small Gains Amid Mixed News
-
ナレーター：
-
著者：
So, here’s what went down. Moderna had a pretty quiet day overall. The volume was right in line with what we usually see, so nothing too dramatic there. It kinda felt like just another day in the office. I mean, it did flirt with the $60 mark, but it didn’t stick. People seemed chill, not too eager to push the stock one way or the other.
Now, let’s chat about why that might be. There’s been a lot of buzz about Moderna’s pipeline lately, especially with the news about their Ebola trial getting the green light in Canada. That’s a big deal and could redefine what the company’s up to. But, on the flip side, there’s also some chatter about the CDC not publishing a report on COVID-19 vaccine effectiveness. That’s got some folks scratching their heads about the vaccine's future. And then there’s this other story about a former pharmacy president getting hit with a massive kickback scheme. Yeah, that one stung for the pharma world. So, with all this mixed news, it seems like investors are just hanging tight, waiting to see how things shake out.
One quick thing to keep in mind is that Contravisory Investment Management just scooped up some shares of Moderna. That could mean they see potential here, but who knows? People have different takes on this stock, and it’s always a mixed bag in the market.
Alright, that’s a wrap for today! Just remember, I’m here sharing info and having fun with this stuff, not giving financial advice. So, keep your chin up and happy investing! Catch you next time!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません